Interferon-α and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials-Reference-Cited by-同舟云学术

Interferon-α and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials

Published:1993-07-15 Issue:2 Volume:72 Page:607-614
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Keilholz Ulrich,Scheibenbogen Carmen,Tilgen Wolfgang,Bergmann Lothar,Weidmann Eckardt,Seither Evi,Richter Max,Brado Bernadett,Mitrou Paris S.,Hunstein Werner

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference27 articles.

1. Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

2. Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

3. A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma.

4. Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients

5. Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokines (IL-2, IFN, GM-CSF, etc.) Melanoma;Cutaneous Melanoma;2020

2. High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort;European Journal of Cancer;2019-07

3. Cytokines (IL-2, IFN GM-CSF etc) Melanoma;Cutaneous Melanoma;2018-10-30

4. The Emerging Therapeutic Landscape of Advanced Melanoma;Current Pharmaceutical Design;2018-05-02

5. Interleukin-2: Old and New Approaches to Enhance Immune-Therapeutic Efficacy;Advances in Experimental Medicine and Biology;2017